Combi-TED

Advertisement

cGxPJobs Banner

OSE to Present Phase 2 Tedopi Data in Metastatic NSCLC

NANTES, France — September 23, 2026 OSE Immunotherapeutics announced that topline results from the Combi-TED Phase 2 trial of...

By cGxPwire Editor
September 24, 2026

Read More

Advertisement

cGxPJobs

Directory